Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FNDC1 intronic transcript 1 (FNDC1-IT1) is a long non-coding RNA (lncRNA) transcribed from the intronic region of the FNDC1 gene, specifically classified as an intronic transcript[3][4]. It does not code for a protein[3][4]. FNDC1-IT1 has been associated with certain cancers, including breast squamous cell carcinoma and breast metaplastic carcinoma, but its precise biological function and mechanism remain unclear[3][5]. There are no established interacting drugs, mechanisms of action, biomarker uses, or safety concerns reported for FNDC1-IT1. Currently, it is not considered a conventional therapeutic target such as a receptor, enzyme, or transporter[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FNDC1 intronic transcript 1 (FNDC1-IT1).